MetaCap

Thermo Fisher Scientific Financial Ratios

NYSE: TMOIndustrialsIndustrial Machinery/ComponentsUSD

658.02+6.04 (+0.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Thermo Fisher Scientific ratio analysis

Thermo Fisher Scientific earned a net margin of 15.0% in FY 2025, up from 14.8% a year earlier. Return on equity reached 12.6%, meaning Thermo Fisher Scientific generated 0.13 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.74 versus 0.63 the year before, and the current ratio was 1.89.

At the end of FY 2025, TMO traded at 33.4 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 27.7 to 35.2, with a median of 32.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Thermo Fisher Scientific financial ratios (annual)

Thermo Fisher Scientific annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)33.4032.1934.3631.2434.2929.1835.2030.6333.9727.72
Price / sales5.014.744.784.816.705.735.063.663.593.05
Price / book4.184.104.384.916.445.354.353.232.952.59
Gross margin————————57.1%55.1%
Operating margin17.4%17.1%16.0%18.7%25.6%24.2%18.0%15.5%14.2%13.5%
Net margin15.0%14.8%14.0%15.5%19.7%19.8%14.5%12.1%10.6%11.1%
Free cash flow margin14.1%16.9%16.2%15.4%17.3%21.2%15.8%15.5%16.7%15.4%
Return on equity (ROE)12.6%12.8%12.8%15.8%18.9%18.5%12.5%10.7%8.8%9.4%
Return on assets (ROA)6.1%6.5%6.1%7.2%8.1%9.2%6.3%5.2%3.9%4.4%
Debt / equity0.740.630.750.780.850.630.600.690.830.77
Current ratio1.891.661.751.481.502.131.921.731.341.44
Revenue growth3.9%0.1%-4.6%14.5%21.7%26.1%4.9%16.4%14.5%7.7%
EPS growth7.3%7.0%-12.4%-9.4%21.9%74.0%26.7%29.5%9.8%3.5%

Related